PIR and cancer: The results showed that the expression of piR-34536 and piR-51810 were down-regulated in renal cell carcinoma compared with non-malignant renal tissues, and the decrease of tissue piRNAs level was a significant independent predictor of the shortening of progression-free survival, cancer-specific survival, and overall survival of ccRCC patients.